申请人:Sumitomo Chemical Company, Limited
公开号:US04060550A1
公开(公告)日:1977-11-29
Indolylacetic acid derivatives, which have excellent anti-inflammatory, antipyretic and analgesic activities, represented by the formula, ##STR1## wherein X.sub.1 and X.sub.2 are each methylene; A is an unsubstituted ethylenically unsaturated hydrocarbon chain having up to 5 carbon atoms; m is 0 or 1; n is 1 or 2; R.sub.3 is alkyl having up to 4 carbon atoms; cycloalkyl having 3 to 7 carbon atoms, unsubstituted or C.sub.1 -C.sub.4 alkyl-, nitro-, trifluoromethyl-, methylenedioxy-, ethylenedioxy- or halogen-substituted phenyl, or halogen-, C.sub.1 -C.sub.4 alkyl- or phenyl-substituted or benzene ring-condensed C.sub.3 -C.sub.7 cycloalkyl, or unsubstituted or halogen-, C.sub.1 -C.sub.4 alkyl- or phenyl-substituted or benzene ring-condensed C.sub.5 -C.sub.6 cycloalkenyl; and B is ##STR2## .
这段文字是关于具有优异的抗炎、退烧和镇痛活性的吲哚乙酸衍生物的描述,其化学式为 ##STR1## 其中X1和X2均为亚甲基;A是未取代的具有5个碳原子以下的乙烯基不饱和碳氢链;m为0或1;n为1或2;R3是具有4个碳原子以下的烷基;具有3到7个碳原子的环烷基,未取代或取代于C1-C4烷基、硝基、三氟甲基、亚甲二氧基、乙二氧基或卤素的苯基,或取代于卤素、C1-C4烷基或苯基的或苯环共轭的C3-C7环烷基,或未取代或取代于卤素、C1-C4烷基或苯基的或苯环共轭的C5-C6环烯基;B为 ##STR2## 。